E-LIB Suche - Ergebnisse für: Toshinari Yamashita

1

Inhibition of lysine acetyltransferase KAT6 in ER+HER2− met..:

Mukohara, Toru ; Park, Yeon Hee ; Sommerhalder, David...
Nature Medicine. , 2024

Link: https://doi.org/10.1038/..

2

Fulvestrant with or without anti‐HER2 therapy in patients i..:

Masuyama, Misato ; Masuda, Norikazu ; Kawaguchi, Hidetoshi...
Cancer Medicine. 12 (2023) 17 - p. 17718-17730 , 2023

Link: https://doi.org/10.1002/..

3

Glutamine deficiency drives transforming growth factor‐β si..:

Mezawa, Yoshihiro ; Wang, Tingwei ; Daigo, Yataro...
Cancer Science. 114 (2023) 11 - p. 4376-4387 , 2023

Link: https://doi.org/10.1111/..

4

Trastuzumab Deruxtecan for the Treatment of HER2-positive B..:

Department of Breast and Endocrine Surgery, Kanagawa Cancer Center, Yokohama, Japan ; Yamashita, Toshinari
Oncology & Haematology. 19 (2023) 1 - p. 6 , 2023

Link: https://doi.org/10.17925..

5

Bone marrow adipocytes induce cancer‐associated fibroblasts..:

Sato, Shinya ; Hiruma, Toru ; Koizumi, Mitsuyuki...
Cancer Science. 114 (2023) 6 - p. 2674-2688 , 2023

Link: https://doi.org/10.1111/..

6

Increased RUNX3 expression mediates tumor‐promoting ability..:

Koyama, Yu ; Okazaki, Hiroya ; Shi, Yang...
Cancer Medicine. 12 (2023) 17 - p. 18062-18077 , 2023

Link: https://doi.org/10.1002/..

7

FXYD3 functionally demarcates an ancestral breast cancer st..:

Li, Mengjiao ; Nishimura, Tatsunori ; Takeuchi, Yasuto...
Journal of Clinical Investigation. 133 (2023) 22 - p. , 2023

Link: https://doi.org/10.1172/..

8

Subgroup analysis of Japanese patients in a phase III rando..:

Saji, Shigehira ; Ohsumi, Shozo ; Ito, Mitsuya...
Japanese Journal of Clinical Oncology. , 2022

Link: https://doi.org/10.1093/..

9

Retrospective study on the effectiveness of medroxyprogeste..:

Kawaguchi, Hidetoshi ; Yamamoto, Yutaka ; Saji, Shigehira...
Japanese Journal of Clinical Oncology. 53 (2022) 3 - p. 203-211 , 2022

Link: https://doi.org/10.1093/..

10

Efficacy and exploratory biomarker analysis of entinostat p..:

Iwata, Hiroji ; Nakamura, Rikiya ; Masuda, Norikazu...
Japanese Journal of Clinical Oncology. 53 (2022) 1 - p. 4-15 , 2022

Link: https://doi.org/10.1093/..

11

Factors associated with overall survival after recurrence i..:

Kawaguchi, Hidetoshi ; Yamamoto, Yutaka ; Saji, Shigehira...
Japanese Journal of Clinical Oncology. 52 (2022) 6 - p. 545-553 , 2022

Link: https://doi.org/10.1093/..

12

Development of an intraoperative breast cancer margin asses..:

Ueo, Hiroki ; Minoura, Itsushi ; Ueo, Hiroaki...
Scientific Reports. 12 (2022) 1 - p. , 2022

Link: https://doi.org/10.1038/..

13

Efficacy and safety of talazoparib in Japanese patients wit..:

Kotani, Haruru ; Masuda, Norikazu ; Yamashita, Toshinari...
Breast Cancer. 29 (2022) 6 - p. 1088-1098 , 2022

Link: https://doi.org/10.1007/..

14

Effect of Trastuzumab Deruxtecan on QT/QTc Interval and Pha..:

Shimomura, Akihiko ; Takano, Toshimi ; Takahashi, Shunji...
Clinical Pharmacology & Therapeutics. 113 (2022) 1 - p. 160-169 , 2022

Link: https://doi.org/10.1002/..

15

Efficacy of Clinical Guidelines in Identifying All Japanese..:

Haneda, Eri ; Sato, Ann ; Suganuma, Nobuyasu...
International Journal of Environmental Research and Public Health. 19 (2022) 10 - p. 6182 , 2022

Link: https://doi.org/10.3390/..